AVCTF
Price
$0.75
Change
-$0.01 (-1.32%)
Updated
Sep 11 closing price
Capitalization
293.82M
EPRX
Price
$5.74
Change
-$0.02 (-0.35%)
Updated
Sep 26 closing price
Capitalization
290.89M
39 days until earnings call
Interact to see
Advertisement

AVCTF vs EPRX

Header iconAVCTF vs EPRX Comparison
Open Charts AVCTF vs EPRXBanner chart's image
Avacta Group
Price$0.75
Change-$0.01 (-1.32%)
Volume$5.01K
Capitalization293.82M
Eupraxia Pharmaceuticals
Price$5.74
Change-$0.02 (-0.35%)
Volume$58.49K
Capitalization290.89M
AVCTF vs EPRX Comparison Chart in %
Loading...
AVCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVCTF vs. EPRX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVCTF is a Buy and EPRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (AVCTF: $0.75 vs. EPRX: $5.74)
Brand notoriety: AVCTF and EPRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVCTF: 137% vs. EPRX: 106%
Market capitalization -- AVCTF: $293.82M vs. EPRX: $290.89M
AVCTF [@Biotechnology] is valued at $293.82M. EPRX’s [@Biotechnology] market capitalization is $290.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVCTF’s FA Score shows that 0 FA rating(s) are green whileEPRX’s FA Score has 0 green FA rating(s).

  • AVCTF’s FA Score: 0 green, 5 red.
  • EPRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both AVCTF and EPRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVCTF’s TA Score shows that 4 TA indicator(s) are bullish while EPRX’s TA Score has 7 bullish TA indicator(s).

  • AVCTF’s TA Score: 4 bullish, 4 bearish.
  • EPRX’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, EPRX is a better buy in the short-term than AVCTF.

Price Growth

AVCTF (@Biotechnology) experienced а 0.00% price change this week, while EPRX (@Biotechnology) price change was -3.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

EPRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVCTF($294M) and EPRX($291M) have the same market capitalization . EPRX YTD gains are higher at: 81.073 vs. AVCTF (32.088).
AVCTFEPRXAVCTF / EPRX
Capitalization294M291M101%
EBITDAN/A-28.83M-
Gain YTD32.08881.07340%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A19.8M-
Total DebtN/A35.1K-
TECHNICAL ANALYSIS
Technical Analysis
AVCTFEPRX
RSI
ODDS (%)
Bearish Trend 1 day ago
46%
Bearish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
33%
Bullish Trend 1 day ago
68%
Momentum
ODDS (%)
Bullish Trend 1 day ago
38%
Bullish Trend 1 day ago
68%
MACD
ODDS (%)
Bearish Trend 1 day ago
38%
Bullish Trend 1 day ago
65%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
33%
Bearish Trend 1 day ago
66%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
35%
Bullish Trend 1 day ago
42%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 17 days ago
30%
Bearish Trend 4 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
55%
Bearish Trend 1 day ago
57%
Aroon
ODDS (%)
Bullish Trend 1 day ago
39%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
AVCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCGLF67.501.01
+1.52%
Societe Generale
AMBK15.76N/A
N/A
American Bank, Inc.
GRCLF5.50-0.03
-0.48%
GrainCorp Ltd.
BLSFY71.95-1.38
-1.88%
Bluescope Steel, Ltd.
PSUD0.01N/A
-14.29%
PetroSun, Inc.

AVCTF and

Correlation & Price change

A.I.dvisor tells us that AVCTF and NAUT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVCTF and NAUT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVCTF
1D Price
Change %
AVCTF100%
N/A
NAUT - AVCTF
29%
Poorly correlated
+0.81%
ACAD - AVCTF
24%
Poorly correlated
-0.75%
EPRX - AVCTF
24%
Poorly correlated
-0.35%
KZIA - AVCTF
23%
Poorly correlated
+0.01%
FBRX - AVCTF
23%
Poorly correlated
-2.88%
More

EPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EPRX has been loosely correlated with NAGE. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if EPRX jumps, then NAGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
-0.35%
NAGE - EPRX
34%
Loosely correlated
+3.72%
ETNB - EPRX
29%
Poorly correlated
N/A
IVEVF - EPRX
28%
Poorly correlated
N/A
ACAD - EPRX
28%
Poorly correlated
-0.75%
IRON - EPRX
26%
Poorly correlated
+4.88%
More